Evidence map›Paper›PMID 17174995›Full record

ArticleSteroids2007

Xenoestrogens are potent activators of nongenomic estrogenic responses.

Cheryl S Watson, Nataliya N Bulayeva, Ann L Wozniak, Rebecca A Alyea

Open access · greenAbstract read
In one paragraph

Article in Steroids, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Estrogen and Bisphenol A in Hypertension.Current hypertension reports · 2020
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Associations between Bisphenol A Exposure and Reproductive Hormones among Female Workers.International journal of environmental research and public health · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Cheryl S WatsonBiochemistry & Molecular Biology Department, University of Texas Medical Branch, Galveston, TX 77555-0645, United States. cswatson@utmb.edu <cswatson@utmb.edu>
Nataliya N Bulayeva
Ann L Wozniak
Rebecca A Alyea
The University of Texas Medical Branch at Galveston · US

Funding

Environmental Estrogens Acting via a Membrane ReceptorR01ES010987 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WATSON, CHERYL S · 2002 to 2004
$660k
NIEHS NIH HHS R01 ES010987
6 · The paper itself

Abstract

Studies of the nuclear transcriptional regulatory activities of non-physiological estrogens have not explained their actions in mediating endocrine disruption in animals and humans at the low concentrations widespread in the environment. However, xenoestrogens have rarely been tested for their ability to participate in the plethora of nongenomic steroid signaling pathways elucidated over the last several years. Here we review what is known about such responses in comparison to our recent evidence that xenoestrogens can rapidly and potently elicit signaling through nongenomic pathways culminating in functional endpoints. Both estradiol (E(2)) and compounds representing various classes of xenoestrogens (diethylstilbestrol, coumestrol, bisphenol A, DDE, nonylphenol, endosulfan, and dieldrin) act via a membrane version of the estrogen receptor-alpha on pituitary cells, and can provoke Ca(2+) influx via L-type channels, leading to prolactin (PRL) secretion. These hormones and mimetics can also cause the oscillating activation of extracellular regulated kinases (ERKs). However, individual estrogen mimetics differ in their potency and temporal phasing of these activations compared to each other and to E(2). It is perhaps in these ways that they disrupt some endocrine functions when acting in combination with physiological estrogens. Our quantitative assays allow comparison of these outcomes for each mimetic, and let us build a detailed picture of alternative signaling pathway usage. Such an understanding should allow us to determine the estrogenic or antiestrogenic potential of different types of xenoestrogens, and help us to develop strategies for preventing xenoestrogenic disruption of estrogen action in many tissues.

Indexed as

AnimalsCalciumCell Line, TumorEstrogens, Non-SteroidalGenomeMolecular MimicryProlactinRatsSignal TransductionCalciumEstrogens, Non-SteroidalProlactin

Identifiers

PMID17174995
PMCPMC1862644
OpenAlexW2086422581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.